Mayne Pharma Group Ltd (ASX:MYX)
A$ 5.3 0.1 (1.92%) Market Cap: 450.89 Mil Enterprise Value: 340.44 Mil PE Ratio: 0 PB Ratio: 0.93 GF Score: 76/100

Mayne Pharma Group Ltd Annual Shareholders Meeting Transcript

Nov 29, 2022 / 10:00PM GMT
Release Date Price: A$5.5 (+1.85%)
Frank Charles Condella
Mayne Pharma Group Limited - Independent Non-Executive Chairman

Welcome, everyone. I'm Frank Condella, Chair of Mayne Pharma, and it's a pleasure to welcome you to Mayne Pharma's 2022 Annual General Meeting. As we have a quorum present, I'm delighted to open the meeting.

We're pleased to be able to offer a hybrid meeting this year and offer shareholders a face-to-face experience for the first time in a couple of years as well as a live webcast via the Computershare meeting platform.

So first of all, today, I'd like to take you through the procedural aspects of the meeting. Shareholders and proxy holders present in the room can ask questions. If you're watching on the webcast and you're a shareholder, you have the ability to ask questions at any time by using the meeting platform. Questions can be submitted on the platform, and you don't need to wait for the relevant item on the business agenda in order to ask your question. We're showing on the screen here now where the Q&A button is. (Operator Instructions) You can also ask verbal questions by following the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot